Normal ex vivo mesenchymal stem cell function combined with abnormal immune profiles sets the stage for informative cell therapy trials in idiopathic pulmonary fibrosis patients.
正常的体外间充质干细胞功能与异常的免疫特征相结合，为特发性肺纤维化患者的细胞治疗试验奠定了基础
期刊:Stem Cell Research & Therapy
影响因子:7.3
doi:10.1186/s13287-021-02692-0
Atanasova Elena, Milosevic Dragana, Bornschlegl Svetlana, Krucker Karen P, Jacob Eapen K, Carmona Porquera Eva M, Anderson Dagny K, Egan Ashley M, Limper Andrew H, Dietz Allan B
